Many Cancer Patients Are Missing Out On The Most Advanced Treatments

Many Cancer Patients Are Missing Out On The Most Advanced Treatments A study in JAMA found that many patients are not receiving genetic sequencing, which can often greatly improve a person's chances of survival. Patients with a low income, Medicare or Medicaid coverage, and those of Black or Hispanic ethnicity were less likely to receive sequencing. Also, advocates worry New York may be rolling back Medicaid coverage of biomarker precision testing. https://kffhealthnews.org/morning-breakout/many-cancer-patients-are-missing-out-on-the-most-advanced-treatments/